ACD Awards $145,000 To Advance Creatine Deficiency Research At Six Research Centers
ACD Fellowship Awardees 2025 Young Investigator Awardee Researchers at six institutions funded by Association for Creatine Defi ...
SMA1d
Spinraza treatment won’t lead to kidney dysfunction, per study
Spinraza treatment does not lead to significant kidney dysfunction in SMA patients with types 1 and 2, a safety and efficacy ...
ZME Science2d
A Single High Dose of Creatine Might Help the Brain to Power Through Sleep Deprivation
For most healthy people, creatine is safe and well-tolerated when used as directed. The most common side effects of creatine ...
TMCnet3d
UPDATE: SpringWorks Therapeutics Announces FDA Approval of GOMEKLI™ (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
GOMEKLI™ is an oral, small molecule MEK inhibitor approved in the United States for the treatment of adult and pediatric patients 2 years of age and older with neurofibromatosis type 1 (NF1) who have ...
PipelineReview.com6d
Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
SOUTH SAN FRANCISCO, CA, USA I 07, 2025 I Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing the power of ...